of human organs intended for transplantation ( COM(2008)0818 – C6‑0480/2008 – 2008/0238(COD) ) (Ordinary legislative procedure: first reading) The European Parliament , – having regard to the Commission proposal to the European Parliament and the Council ( COM(2008)0818 ), – having regard to Article 251(2) and Article 152(4)(a) of the EC Treaty, pursuant to which the Commission submitted the proposal to Parliament ( C6‑0480/2008 ), – having regard to the Communication from the Commission to the European Parliament and the Council entitled "Consequences of the entry into force of the Treaty of Lisbon for ongoing interinstitutional decision-making procedures" ( COM(2009)0665 ), – having regard to Article 294(3) and Article 168(4) of the Treaty on the Functioning of the EU, – having regard to Rule 55 of its Rules of Procedure, – having regard to the report of the Committee on the Environment, Public Health and Food Safety and the opinion of the Committee on Legal Affairs ( A7‑0106/2009 ), 1. Adopts the position at first reading hereinafter set out; 2. Calls on the Commission to refer the matter to Parliament again if it intends to amend its proposal substantially or replace it with another text. 3. Instructs its President to forward its position to the Council and the Commission and to the national parliaments. Amendment 1 Proposal for a directive Recital 1 Text proposed by the Commission Amendment (1) Over the past 50 years organ transplantation has become an established worldwide practice, bringing immense benefits to hundreds of thousands of patients. The use of human organs for transplantation has steadily increased during the last two decades. Organ transplantation is now the most cost-effective treatment for end-stage renal failure, while for end-stage failure of organs such as the liver, lung and heart it is the only available treatment. (1) Over the past 50 years organ transplantation has become an established worldwide practice, bringing immense benefits to hundreds of thousands of patients. The use of human organs for transplantation has steadily increased during the last two decades. Organ transplantation is now the treatment with the best risk/benefit ratio for end-stage renal and pancreatic failure, while for end-stage failure of organs such as the liver, lung , intestines and heart it is the only available treatment. Justification If the organ transplantations which are feasible according to the state of the art are to be listed, it is important to ensure that the list